A sweeping federal court ruling on March 17, 2026 has temporarily blocked efforts by US Health Secretary Robert F. Kennedy Jr. and the Trump administration to change national immunization policies. The judge’s decision, citing lack of scientific basis and procedural lapses, marks a significant setback for Kennedy’s vaccine agenda and the Trump administration’s revised vaccination policy. The ruling has immediate implications for ongoing public health debates and the future direction of US vaccine regulations.Süddeutsche Zeitung+2
The federal judge invalidated decisions made by Robert F. Kennedy Jr. regarding vaccination policies, specifically criticizing the lack of scientific foundation behind the proposed changes. The court found Kennedy’s efforts to reduce recommended immunizations and restructure the vaccine advisory committee to be “arbitrary and capricious.” All votes and actions by the restructured advisory committee over the past year have been stayed, and upcoming meetings postponed. The ruling also temporarily halts the Trump administration’s revised vaccination policy, emphasizing the need for evidence-based decision-making in federal health measures.Süddeutsche Zeitung+2
This injunction disrupts the Department of Health’s plans to cut the number of recommended childhood vaccines and affects both the Trump and Biden administrations. The court’s decision is seen as a victory for public health advocates and organizations such as the American Academy of Pediatrics, who challenged the changes. The ruling also led to the early retirement of controversial border protector Bovino, highlighting broader administrative shakeups. The decision underscores the importance of scientific integrity and procedural rigor in shaping national health policy.Süddeutsche Zeitung+2
Medical professionals and advocacy groups have welcomed the court’s intervention, but doctors warn that mistrust and fear generated by recent policy changes may persist for years. The controversy has heightened scrutiny of federal vaccine policy and is expected to influence state-level vaccination debates. The ruling reinforces the need for transparent, evidence-based policymaking amid ongoing disputes about childhood immunization and public health strategy.The New York Times+2